251 related articles for article (PubMed ID: 27121963)
1. Construction and analysis of protein-protein interaction networks based on proteomics data of prostate cancer.
Chen C; Shen H; Zhang LG; Liu J; Cao XG; Yao AL; Kang SS; Gao WX; Han H; Cao FH; Li ZG
Int J Mol Med; 2016 Jun; 37(6):1576-86. PubMed ID: 27121963
[TBL] [Abstract][Full Text] [Related]
2. Protein expression information of prostate infection based on data mining.
Abula A; Shao W; Tusong H; Wang F; Yasheng A; Wang Y; Wang Y
J Infect Public Health; 2020 Oct; 13(10):1533-1536. PubMed ID: 31422041
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of ocular complications in atherosclerosis unveils pathway convergence and crosstalk.
Gupta A; Mohanty P; Bhatnagar S
J Recept Signal Transduct Res; 2015 Apr; 35(2):149-64. PubMed ID: 25055025
[TBL] [Abstract][Full Text] [Related]
4. Identification of hub subnetwork based on topological features of genes in breast cancer.
Zhuang DY; Jiang L; He QQ; Zhou P; Yue T
Int J Mol Med; 2015 Mar; 35(3):664-74. PubMed ID: 25573623
[TBL] [Abstract][Full Text] [Related]
5. Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.
Murugesan SN; Yadav BS; Maurya PK; Chaudhary A; Singh S; Mani A
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180040
[TBL] [Abstract][Full Text] [Related]
6. Construction and analysis of a protein-protein interaction network related to self-renewal of mouse spermatogonial stem cells.
Xie W; Sun J; Wu J
Mol Biosyst; 2015 Mar; 11(3):835-43. PubMed ID: 25566695
[TBL] [Abstract][Full Text] [Related]
7. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.
Davalieva K; Kostovska IM; Kiprijanovska S; Markoska K; Kubelka-Sabit K; Filipovski V; Stavridis S; Stankov O; Komina S; Petrusevska G; Polenakovic M
Prostate; 2015 Oct; 75(14):1586-600. PubMed ID: 26074449
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
9. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive data mining reveals RTK/RAS signaling pathway as a promoter of prostate cancer lineage plasticity through transcription factors and CNV.
Wei G; Zhang X; Liu S; Hou W; Dai Z
Sci Rep; 2024 May; 14(1):11688. PubMed ID: 38778150
[TBL] [Abstract][Full Text] [Related]
11. The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
Luna-Coronell JA; Vierlinger K; Gamperl M; Hofbauer J; Berger I; Weinhäusel A
Proteomics; 2016 Apr; 16(8):1204-14. PubMed ID: 27089054
[TBL] [Abstract][Full Text] [Related]
12. Identification of human prolactinoma related genes by DNA microarray.
Zhao L; Lin M; Wang S
J Cancer Res Ther; 2014; 10(3):544-8. PubMed ID: 25313736
[TBL] [Abstract][Full Text] [Related]
13. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
14. Identification of key regulators in prostate cancer from gene expression datasets of patients.
Mangangcha IR; Malik MZ; Küçük Ö; Ali S; Singh RKB
Sci Rep; 2019 Nov; 9(1):16420. PubMed ID: 31712650
[TBL] [Abstract][Full Text] [Related]
15. Mining featured biomarkers associated with prostatic carcinoma based on bioinformatics.
Piao G; Wu J
Biomarkers; 2013 Nov; 18(7):580-6. PubMed ID: 23957850
[TBL] [Abstract][Full Text] [Related]
16. Proteomic analysis of zoledronic-acid resistant prostate cancer cells unveils novel pathways characterizing an invasive phenotype.
Milone MR; Pucci B; Bifulco K; Iannelli F; Lombardi R; Ciardiello C; Bruzzese F; Carriero MV; Budillon A
Oncotarget; 2015 Mar; 6(7):5324-41. PubMed ID: 25481874
[TBL] [Abstract][Full Text] [Related]
17. Label-free quantitative phosphoproteomic analysis reveals differentially regulated proteins and pathway in PRRSV-infected pulmonary alveolar macrophages.
Luo R; Fang L; Jin H; Wang D; An K; Xu N; Chen H; Xiao S
J Proteome Res; 2014 Mar; 13(3):1270-80. PubMed ID: 24533505
[TBL] [Abstract][Full Text] [Related]
18. Signaling pathway networks mined from human pituitary adenoma proteomics data.
Zhan X; Desiderio DM
BMC Med Genomics; 2010 Apr; 3():13. PubMed ID: 20426862
[TBL] [Abstract][Full Text] [Related]
19. Variant analysis of prostate cancer in Japanese patients and a new attempt to predict related biological pathways.
Kasajima R; Yamaguchi R; Shimizu E; Tamada Y; Niida A; Tremmel G; Kishida T; Aoki I; Imoto S; Miyano S; Uemura H; Miyagi Y
Oncol Rep; 2020 Mar; 43(3):943-952. PubMed ID: 32020225
[TBL] [Abstract][Full Text] [Related]
20. An integrative proteomics and interaction network-based classifier for prostate cancer diagnosis.
Jiang FN; He HC; Zhang YQ; Yang DL; Huang JH; Zhu YX; Mo RJ; Chen G; Yang SB; Chen YR; Zhong WD; Zhou WL
PLoS One; 2013; 8(5):e63941. PubMed ID: 23737958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
